Genetic marker analysis in head and neck cancer;Genetikai marker-vizsgálatok fej-nyaki daganatokban

Magyar Onkologia

Volumn 45, Issue 2, 2001, Pages 161-167

  Orsolya, Csuka ^a   Judit, Olasz ^a   Alíz, Juhász ^a   Árpád, Hargitai ^a   Éva, Remenár ^b   Miklós, Kásler ^b  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b Laser es Helyreallito Plasztikai Sebészeti Osztály   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34948844020     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Baek MJ, Piao Z, Kim NG, et al. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 89:60-68, 2000
2. Birchall MA, Winterford CM, Allan PJ, Hermon BV. Apoptosis in normal, premalignant and malignant lesions of the oropharynx and oral cavity: A preliminary study. Eur J Cancer 31B:380-383, 1995
3. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56:2488-2492, 1996
4. Carey TE. Field cancerization: Are multiple primary cancer monoclonal or polyclonal. Ann Med 28:183-188, 1996
5. Cruz IB, Snijders PJF, Meijer CJ, et al. p53 expression above the basal cell layer in oral mucosa is an erly event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 184:360-368, 1999
6. Wei Q, Eicher SA, Guan Y, et al. Reduced expression of hMLH1 and hGTBP/hMSH6: A risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev 7:309-314, 1998
7. El-Naggar AK, Zai S, Clayman G, et al. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 151:1767-1774, 1997
8. Gallo O, Chiarelli I, Boddi V, et al. Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy. Int J Cancer 84:573-579, 1999
9. Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55:4531-4535, 1995
10. Homann N, Nees M, Conradt C, et al. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res 7:290-296, 2001
11. Ilyas M, Tomlinson PM. The interaction of APC, E-cadherin and ß catenin in tumor development and progression. J Pathol 182:128-137, 1997
12. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repairdefective human tumor cell lines. Cancer Res 57:808-811, 1997
13. Kosmidis PA. Head and neck cancer. Euro Cancer News 6:9-13, 1993
14. Luce MC, Marra G, Chauhan DP, et al. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 1090:1368-1374, 1995
15. Lydiatt MW, Pavidson B, Schantz SP, et al. 9p21 deletion correlates with recurrence in head and neck cancer. Head Neck 20:113-118, 1998
16. Lynch HT, Smyrk T. Hereditary non-polyposis colorectal cancer. An update review. Cancer 78:1140-1167, 1996
17. Ma L, Ronai A, Riede UN, Kohler G. Clinical implication of screening p53 gene mutations in head and neck squamous cell carcinomas. Oncology 124:389-396, 1998
18. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299, 1995
19. Nogueira CH, Rober W, Vaughan W, et al. Inactivation of p53 and amplification of Cyclin D correlate with clinical outcome in head and neck cancer. Laryngoscope 108:345-350, 1998
20. Pruneri G, Pignataro L, Carboni N, et al. Clinical relevance of p53 and Bcl-2 protein over-expression in laryngeal squamous-cell carcinoma. Int J Cancer 79:263-268, 1996
21. Schipper JH, Frixen U, Behrens J, et al. E-Cadherin expression in squamous cell carcinomas of head and neck. Cancer Res 51:6328-6337, 1991
22. Shin DM, Lee JS, Lippman SM, et al. p53 expression: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst 88:519-529, 1996
23. Slaughter TP, Southwich HW, Smejkel W. Field cancerization in oral stratified epithelium. Cancer 6:963-968, 1993
24. Souza RF, Yin J, Smolinski KN, et al. Frequent mutation of the E2F4 cell cycle gene in primary human gastrointestinal tumors. Cancer Res 57:2350-2353, 1997
25. Tjebbes GWA, Leppers vd Straat FGJ, Tilanus MGJ, et al. P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: P53 mutations in primary tumor and matched lymph node metastases. Oral Oncol 35:384-389, 1999
26. Wilson GD, Richman PI, Sanders M. P53 status of head and neck cancer, relation to biological characteristics and outcome of radiotherapy. Br J Cancer 71:1248-1252, 1995
27. Xie X, Clausen OP, De Angelis P, Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2 and p53 in oral squamous cell carcinoma of the tongue. Cancer 86:913-920, 1999